Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
14,525,788
-
Share change
-
+580,390
-
Total reported value
-
$20,043,824
-
Price per share
-
$1.38
-
Number of holders
-
41
-
Value change
-
+$813,702
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q3 2022
As of 30 Sep 2022 Vincerx Pharma, Inc. - Common Stock (VINC) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,525,788 shares of stock of the company.
Largest 10 holders included Rubric Capital Management LP, SAGE RHINO CAPITAL LLC, Affinity Asset Advisors, LLC, Rock Springs Capital Management LP, Long Focus Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Holocene Advisors, LP, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and SABBY MANAGEMENT, LLC.
This table shows 41 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.